Supply Chain Security and Growth Act of 2025
Rep. Malliotakis Leads Bipartisan Push for 40% Tax Credit to Reshore Critical Manufacturing
The Supply Chain Security and Growth Act of 2025 is currently in the early stages of the legislative process. It was recently introduced and sent to the House Committee on Ways and Means for review. The bill is actively moving forward as it awaits further consideration by the committee.
Legislative Progress
The bill has strong bipartisan support and addresses popular concerns about supply chains, but major tax changes often face delays in a divided Congress.
Key Points
Impact Analysis
Personal Impact
Life & Work
Small manufacturers in the pharmaceutical, semiconductor, aerospace, and medical device sectors could benefit from a 40% investment tax credit when building facilities in U.S. territories. The elective payment option means even smaller firms without large tax liabilities can receive the credit as a direct cash payment, lowering the financial barrier to entry for reshoring production.
“If a taxpayer other than an entity described in subparagraph (A) makes an election under this subparagraph with respect to any taxable year in which such taxpayer has placed in service a critical supply chain facility”
Programs
Disabilities
State Impacts
Milestones
Referred to the House Committee on Ways and Means.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
Votes
No votes have been recorded for this legislation yet.
Related News
2 articlesMalliotakis Leads Bipartisan Legislation to Strengthen U.S. Medical & Pharmaceutical Supply Chains
Rep. Malliotakis reintroduced the Supply Chain Security and Growth Act of 2025, bipartisan legislation leveraging Investment Tax Credits (ITCs) to facilitate the movement of critical U.S. supply chains to Puerto Rico from unreliable locations such as China.
Marco Rubio promised an economic focus on American industry. Now he’s filed the bills.
Senator Marco Rubio filed a series of bills including the MMEDS Act, which enacts a tax credit for companies making medical devices or pharmaceuticals in other countries to move production to the U.S. or Puerto Rico, specifically targeting economically distressed zones.
Source Information
Document Type
Congressional Bill
Official Title
Supply Chain Security and Growth Act of 2025
Data Sources
Sponsor
Cosponsors
(12)Analysis generated by AI. Always verify with official sources.